Epidemiology and Costs of Hypertension-related Disorders

By  

Current Pharmaceutical Design, Vol. 17, Iss. 28, 2011-09 ,pp. : 2955-2972

Bentham Science Publishers

Access to resources Recommend Favorite

Patterns and Costs for Hypertension Treatment in the United States: Clinical, Lifestyle and Socioeconomic Predictors from the 1987 National Medical Expenditures Survey

By Huttin C.  

Clinical Drug Investigation, Vol. 20, Iss. 3, 2000-09 ,pp. : 181-195

Adis International

Access to resources Recommend Favorite

Melatonin attenuates hypertension-related proarrhythmic myocardial maladaptation of connexin-43 and propensity of the heart to lethal arrhythmias 1

By Viczenczova Csilla  

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 8, 2013-03 ,pp. : 633-639

NRC Research Press

Access to resources Recommend Favorite

Editorial [Hot Topic: Modifying Cardiovascular Risk Factors: Epidemiology and Characteristics of Hypertension-Related Disorders (Executive Guest Editor: Aurelio Leone)]

By  

Current Pharmaceutical Design, Vol. 17, Iss. 28, 2011-09 ,pp. : 2948-2954

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of pulmonary arterial hypertension with bosentan: from pathophysiology to clinical evidence

By Provencher Steeve   Sitbon Olivier   Simonneau Gérald  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 8, 2005-07 ,pp. : 1337-1348

Informa Healthcare

Access to resources Recommend Favorite